UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 456

Sortiert nach

Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of LenabasumTM

Arthritis research & therapy, 2022-03, Vol.24 (1), p.69-69, Article 69

2022

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM

Arthritis research & therapy, 2022-01, Vol.24 (1), p.1-12, Article 12

2022

Link zum Volltext

Verfügbarkeit prüfen

Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus [version 1; peer review: 3 approved]

F1000 research, 2019, Vol.8, p.332

2019

Link zum Volltext

Verfügbarkeit prüfen

Retrospective review of patients with chronic lymphocytic leukemia treated with Mohs surgery for nonmelanoma skin cancer

JAAD international, 2023-12, Vol.13, p.170-171

2023

Link zum Volltext

Verfügbarkeit prüfen

Porcine-human glioma xenograft model. Immunosuppression and model reproducibility

Cancer treatment and research communications, 2024, Vol.38, p.100789-100789, Article 100789

2024

Link zum Volltext

Verfügbarkeit prüfen

Histopathologic characterization of onychomycosis in nail biopsies: A retrospective case series of 19 patients

Journal of cutaneous pathology, 2023-02, Vol.50 (2), p.103-105

2023

Link zum Volltext

Verfügbarkeit prüfen

Myeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness

Journal of investigative dermatology, 2021-08, Vol.141 (8), p.1906-1914.e2

2021

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in Pharmacological Treatments of Adult Dermatomyositis

Current rheumatology reports, 2019-10, Vol.21 (10), p.53-53, Article 53

2019

Link zum Volltext

Verfügbarkeit prüfen

Increased MxA protein expression and dendritic cells in spongiotic dermatitis differentiates dermatomyositis from eczema in a single‐center case‐control study

Journal of cutaneous pathology, 2021-03, Vol.48 (3), p.364-373

2021

Link zum Volltext

Verfügbarkeit prüfen

Pediatric patients with orofacial granulomatosis likely to subsequently develop intestinal Crohn's disease: Brief Report

Pediatric dermatology, 2020-11, Vol.37 (6), p.1162-1164

2020

Link zum Volltext

Verfügbarkeit prüfen

Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials

Lupus, 2022-04, Vol.31 (4), p.472-481

2022

Link zum Volltext

Verfügbarkeit prüfen

Progressive blistering and hypertrichosis in a young child

Pediatric dermatology, 2019-11, Vol.36 (6), p.951-952

2019

Link zum Volltext

Verfügbarkeit prüfen

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo

Oncotarget, 2018-12, Vol.9 (97), p.37026-37041

2018

Link zum Volltext

Verfügbarkeit prüfen

The endothelial protein C receptor plays an essential role in the maintenance of pregnancy

Science advances, 2020-11, Vol.6 (45)

2020

Link zum Volltext

Verfügbarkeit prüfen

16741 Pediatric patients with orofacial granulomatosis likely to develop intestinal Crohn disease

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.AB184-AB184

2020

Link zum Volltext

Verfügbarkeit prüfen

Myeloid dendritic cells are major producers of interferon-β in dermatomyositis and may contribute to hydroxychloroquine refractoriness

Journal of investigative dermatology, 2021-03, Vol.141 (8), p.1906-1914.e2

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of autoimmune blistering diseases in pregnancy and the neonate

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2019-10, Vol.154 (5), p.539

2019

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Cannabinoid type 2 receptor and in vivo efects of LenabasumTM

Arthritis research & therapy, 2022-03, Vol.24 (1)

2022

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid type 2 receptor and in vivo effects of LenabasumTM

Arthritis research & therapy, 2022-01, Vol.24 (1)

2022

Link zum Volltext

Verfügbarkeit prüfen

AB017. Increased dendritic cells and IFN-beta and MxA protein expression in spongiotic dermatitis differentiates dermatomyositis from eczema

Annals of translational medicine, 2021-03, Vol.9 (5), p.AB017-AB017

2021

Link zum Volltext

Verfügbarkeit prüfen

AB003. Increased CD69+ tissue-resident memory T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials

Annals of translational medicine, 2021-03, Vol.9 (5), p.AB003-AB003

2021

Link zum Volltext

Verfügbarkeit prüfen

AB018. Myeloid dendritic cells (mDCs) are major producers of interferon-beta in dermatomyositis and increased numbers of mDCs are found in hydroxychloroquine nonresponders

Annals of translational medicine, 2021-03, Vol.9 (5), p.AB018-AB018

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of Lenabasum TM

Arthritis research & therapy, 2022-03, Vol.24 (1), p.69

2022

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of Lenabasum TM

Arthritis research & therapy, 2022-01, Vol.24 (1), p.12

2022

Link zum Volltext

Verfügbarkeit prüfen

Glucocorticoid-Induced Bone Loss: Dietary Supplementation Recommendations to Reduce the Risk for Osteoporosis and Osteoporotic Fractures

Cutis (New York, N.Y.), 2022-10, Vol.110 (4), p.201-206

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 456

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(435)
Mit Volltextzugriff
(410)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of LenabasumTM

Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM

Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus [version 1; peer review: 3 approved]

Retrospective review of patients with chronic lymphocytic leukemia treated with Mohs surgery for nonmelanoma skin cancer

Porcine-human glioma xenograft model. Immunosuppression and model reproducibility

Histopathologic characterization of onychomycosis in nail biopsies: A retrospective case series of 19 patients

Myeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness

Recent Advances in Pharmacological Treatments of Adult Dermatomyositis

Increased MxA protein expression and dendritic cells in spongiotic dermatitis differentiates dermatomyositis from eczema in a single‐center case‐control study

Pediatric patients with orofacial granulomatosis likely to subsequently develop intestinal Crohn's disease: Brief Report

Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials

Progressive blistering and hypertrichosis in a young child

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo

The endothelial protein C receptor plays an essential role in the maintenance of pregnancy

16741 Pediatric patients with orofacial granulomatosis likely to develop intestinal Crohn disease

Myeloid dendritic cells are major producers of interferon-β in dermatomyositis and may contribute to hydroxychloroquine refractoriness

Management of autoimmune blistering diseases in pregnancy and the neonate

Correction to: Cannabinoid type 2 receptor and in vivo efects of LenabasumTM

Cannabinoid type 2 receptor and in vivo effects of LenabasumTM

AB017. Increased dendritic cells and IFN-beta and MxA protein expression in spongiotic dermatitis differentiates dermatomyositis from eczema

AB003. Increased CD69+ tissue-resident memory T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials

AB018. Myeloid dendritic cells (mDCs) are major producers of interferon-beta in dermatomyositis and increased numbers of mDCs are found in hydroxychloroquine nonresponders

Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of Lenabasum TM

Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of Lenabasum TM

Glucocorticoid-Induced Bone Loss: Dietary Supplementation Recommendations to Reduce the Risk for Osteoporosis and Osteoporotic Fractures

Suchergebnisse filtern